In a multiple-dose pharmacokinetic study conducted with the tablet formulation in healthy adult subjects, four subjects were found to be poor metabolisers of desloratadine.
Tervetel täiskasvanutel tabletivormi mitmekordsete annustega läbiviidud farmakokineetilises uuringus täheldati neljal osalejal desloratadiini nõrka metaboliseerumist.